Healthcare M&A and Valuation
News and Insights

On October 2, 2025, New Enterprise Associates (NEA) completed a take private transaction involving NeueHealth, Inc., a provider of value-based care solutions that integrates patient engagement, care coordination, and provider enablement tools aimed at improving clinical outcomes and reducing total cost of care. NeueHealth’s platform partners with provider organizations and payors to deliver risk-bearing care models, leveraging data analytics, technology-driven workflows, an

On September29, 2025, Ambac Financial Group, a specialty financial services company focused on insurance, reinsurance, and related risk-based products, announced its acquisition of ArmadaCare, a provider of comprehensive home care and personal support services serving aging and medically complex populations. ArmadaCare’s offering includes non-medical personal care, companion support, and community-based assistance tailored to seniors and individuals with functional limitati

On September 26, 2025, dentalcorp Holdings Ltd. (TSX: DNTL), Canada’s largest dental service organization (DSO), entered into a definitive arrangement agreement to be acquired by investment funds affiliated with private equity firm GTCR in an all‑cash take‑private transaction valued at approximately C$2.2 billion on an equity basis and C$3.3 billion on an enterprise value basis, or roughly $2.4 billion USD. The acquisition deepens GTCR’s presence in the dental services and m

On September 22, 2025, Premier, Inc. a Charlotte‑based, technology‑driven healthcare improvement company specializing in supply chain solutions, data analytics, consulting and collaborative services for hospitals, health systems and other providers, agreed to be acquired by an affiliate of dedicated healthcare investment firm Patient Square Capital in a take‑private transaction valued at approximately $2.6 billion. Under the terms of the deal, Premier stockholders are receiv

On September 23, 2025, Privia Health Group, Inc. (Nasdaq: PRVA) entered into a definitive agreement to acquire the Accountable Care Organization (ACO) business of Evolent Health, Inc. (NYSE: EVH), operating under the Evolent Care Partners (ECP) brand. The transaction provides Privia with more than 120,000 attributed lives across the Medicare Shared Savings Program (MSSP) as well as various commercial and Medicare Advantage programs, expanding Privia’s total value‑based care

On September 16, 2025, Strata Critical Medical, Inc. (Nasdaq: SRTA) announced the acquisition of Keystone Perfusion Services LLC, a leading provider of organ recovery and normothermic regional perfusion (NRP) services, in a transaction valued at approximately $124 million in upfront consideration. The purchase price was paid roughly 88 % in cash and 12 % in Strata common stock, and Strata agreed to additional contingent earn‑outs of up to $23 million tied to future gross pr

On August 15, 2025, Cardinal Health (NYSE: CAH) announced its acquisition of Solaris Health, the leading urology‑focused management services organization (MSO) in the U.S., in a strategic transaction valued at approximately $1.9 billion in cash consideration, with additional equity rollover bringing implied total deal value closer to $2.4 billion. The deal expands Cardinal’s multi‑specialty MSO platform, The Specialty Alliance, by adding more than 750 providers across 250+

The hospice industry plays a critical role in the U.S. healthcare system, providing compassionate, end-of-life care to patients with terminal illnesses. Hospice services include pain management, symptom relief, counseling, and support for both patients and their families. The industry is heavily regulated and deeply influenced by reimbursement policy, but it continues to be a highly active sector for M&A, driven by demographic tailwinds and the ongoing aging of the U.S. popul

On August 1, 2025, ATI Physical Therapy, Inc. (OTC: ATIP), a leading U.S. provider of outpatient physical therapy and rehabilitation services operating hundreds of clinics across more than 20 states, transitioned from a publicly traded company to private ownership through a merger led by existing stockholders and private investment firms Knighthead Capital Management and Marathon Asset Management. Under the definitive merger agreement, stockholders not affiliated with the in

In July 2025, Aurobindo Pharma USA Inc., the wholly owned U.S. subsidiary of Indian generics manufacturer Aurobindo Pharma Ltd., entered into a definitive agreement to acquire Lannett Co., Inc., a U.S. based producer of complex generic pharmaceuticals, for an enterprise value of approximately $250 million on a cash‑free, debt‑free basis. The transaction, which is expected to close within 8–12 months pending regulatory approvals, will provide Aurobindo with full ownership of

The primary care industry serves as the cornerstone of the healthcare system, providing essential, first-contact medical services to individuals and families across a wide range of demographics. Primary care physicians (PCPs), including family practitioners, internists, pediatricians, and geriatricians, focus on preventive care, chronic disease management, and acute illness treatment. The industry is increasingly shifting toward value-based care models, driven by healthcare r

The home health sector is one of the largest areas of post-acute healthcare, with volume growth driven by both demographic pressures and patient preference for care in the home. Services range from skilled nursing and therapy delivered under a physician’s order (medical home health) to non-medical assistance with activities of daily living such as bathing, dressing, and meal preparation (personal care). While both segments share common growth drivers, their operating models,